Skip to main content

Advertisement

Table 2 Univariate and multivariate analyses of factors predicting disease-free survival (n = 38)

From: Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients

  Univariate Multivariate
  RR 95 % CI P-value RR 95 % CI P-value
Age 1.149 0.3154 – 4.190 0.8328 1.162 0.1601 – 4.622 0.8607
FIGO stage 1.877 0.4963 – 7.102 0.3535 2.524 0.2284 – 27.89 0.4501
Lymph node metastasis 1.937 0.5174 – 7.248 0.3263 1.197 0.4152 – 8.85 0.4044
Parametrium invasion 3.155 0.9579 – 11.76 0.0681 1.716 0.0402 – 8.416 0.691
Margin positive 3.884 0.3645 – 685.0 0.1581 1.604 0.03867 – 10.06 0.7392
Primary tumor > 4 cm 0.3786 0.05758 – 1.266 0.1609 0.3811 0.2314 – 29.76 0.4362
Serum SCC antigen > 5.0 ng/mL 0.6878 0.1982 – 2.365 0.5545 0.2663 0.04308 – 1.646 0.1545
LVSI 8.698 1.508 – 18.00 0.011* 9.764 0.7944 – 120.0 0.07506
Shrinkage rate 50 % 6.098 2.328 – 37.18 0.0021* 12.14 1.023 – 144.1 0.04794*
  1. RR Relative risk, CI Confidence interval, Univariate analysis, Log rank test; Multivariate analysis, Cox proportional hazard model; *significant p-value